BRIEF published on 04/24/2026 at 11:35, 8 days 1 hour ago Sartorius AG Extends CFO Florian Funck's Tenure Executive Board Sartorius AG Biopharmaceutical Industry Financial Leadership Florian Funck
PRESS RELEASE published on 04/24/2026 at 11:30, 8 days 1 hour ago Sartorius AG Supervisory Board extends appointment of board member Florian Funck Sartorius AG extends CFO Florian Funck's term on the Executive Board until 2032. Learn more about Funck's background and Sartorius AG's financial calendar and divisions CFO Executive Board Supervisory Board Sartorius AG Florian Funck
BRIEF published on 04/23/2026 at 07:05, 9 days 5 hours ago Sartorius Reports Strong Start to 2026 with Revenue Growth Revenue Growth Profit Margin Bioprocess Solutions 2026 Guidance Lab Division
PRESS RELEASE published on 04/23/2026 at 07:00, 9 days 5 hours ago Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1% Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
BRIEF published on 03/26/2026 at 16:25, 1 month 6 days ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 1 month 6 days ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 1 month 6 days ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
PRESS RELEASE published on 03/26/2026 at 15:23, 1 month 6 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 1 month 16 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
PRESS RELEASE published on 03/17/2026 at 06:59, 1 month 16 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
Published on 05/02/2026 at 01:30, 11 hours 26 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 12 hours 6 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 12 hours 56 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 12 hours 56 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 14 hours 26 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/01/2026 at 19:23, 17 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 19 hours 11 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 19 hours 35 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 20:00, 1 day 16 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 17 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 17 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 18 hours ago Minutes of the Combined General Meeting held on April 30, 2026
